Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.3, replacing the previous v3.6.2, indicating a minor internal version increment.
    Difference
    0.1%
    Check dated 2026-07-03T22:09:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2 instead of v3.6.0, reflecting a system update. This change does not modify the study content or user-facing information beyond the version label.
    Difference
    0.1%
    Check dated 2026-06-26T23:52:19.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A set of indexing terms, regulatory data flags, and page metadata were removed from the study page, reducing searchable keywords and labels while leaving the core study details accessible.
    Difference
    18%
    Check dated 2026-06-19T23:01:04.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Adds new quick-access sections for joining and contacting the study (Check who can join, How to Join a Study, Find Contact Information) and guidance pages (How to Read a Study Record, Common Questions), plus a site revision note (Revision: v3.6.0). Removes an older Interventions/Treatment heading with different formatting and trims out some topic tags (Ovarian cancer, MedlinePlus Genetics) to streamline the page.
    Difference
    0.6%
    Check dated 2026-06-12T16:47:34.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Ovarian cancer is added as a related topic and MedlinePlus Genetics is listed under related topics. The page shows a new revision line: Revision: v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-05T16:36:47.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.5.4 was added and the previous tag Revision: v3.5.3 was removed. This indicates an administrative update to the study record rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-15T05:41:46.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.